Pfizer-Lilly drug shown to help reduce back pain in late-stage trial
A non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co succeeded in reducing chronic low back pain when used in a stronger dose, results from a late-stage study showed on Tuesday.
from Reuters: Health News https://reut.rs/2TXTLgS
http://bit.ly/2zwRqiM
February 19, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on February 19, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.